Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

Published loading...Updated

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock

Summary by MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of United Therapeutics stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $515.03, for a total value of $4,892,785.00. Following the transaction, the chief executive officer directly owned 324,443 shares of the company's stock, valued at $167,097,878.29. The trade was a 2.84% decrease in their posi…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal